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Objectives. To construct a frailty index from next-of-kin information of the last year of life of community-dwelling 50 years old
or older adults and test its association with health services utilization. Methods. Cross-sectional analysis from next-of-kin data
available from the last wave of the Mexican Health and Aging Study (MHAS). Measurements. Along with descriptive statistics,
the frailty index (FI) was tested in regression models to assess its association with adverse outcomes previous to death: number of
hospitalized days in the previous year and number of visits to a physician in the previous year, in unadjusted and adjusted models.
Results. From a total of 2,649 individuals the mean of age was 74.8 (±11.4) and 56.3% (n = 1,183) were women. The mean of the
FI was of 0.279 (±SD 0.131, R = 0.0–0.738) and distribution was biased to the right. There was a significant association (p < 0.001)
between the FI and number of hospitalized days (𝛽 = 45.7, 95% CI 36.1–55.4, p < 0.001) and for the number of visits to a physician
(𝛽 = 25.93, 95% CI 19.27–32.6, p < 0.001) both models adjusted for age and sex. Conclusion. The FI constructed with next-of-kin
data showed similar characteristics to similar indexes of older adults. It was independently associated with health care use.
1. Introduction
Aging is a growing phenomenon all around the world. Along
with this increase in the number of humans in the highest
range of age, several problems come along [1]. Frailty is one
of these problems, due to worsening of health condition of
the frail older adult, having a higher proportion of adverse
outcomes and elevated usage of health care. Moreover, it
has been noted by previous research that a considerable
number of older adults are frail in the last year of their lives
[2–4]. However it is not common that health professionals
routinely measure frailty, and some of the available datasets
in order to study geriatric epidemiology lack appropriate
measurements to operationalize frailty, rendering it invisible
for quite a while [5]. On the other hand, the frailty index
allows integrating an accurate measurement of frailty from
different number of sources, even if these sources do not have
frailty measurements [6]. Some works on this matter have
shown that medical files—in particular from comprehensive
geriatric assessments—could be used for this purpose (e.g.,
constructing a frailty index); however this information is dif-
ficult to obtain and in many cases restricted to physicians [7].
The frailty index has been shown to be useful in a number
of different settings in order to assess frail older adults. For
example, a recent study has shown how the frailty index (FI)
can be used in the allocation of financial resources to nursing
homes [8], pointing to the fact of the potential use of an FI
for other purposes apart from health care. Moreover, indexes
derived from the comprehensive geriatric assessment (CGA)
have been also described and are derived from over three
decades of the best available tool for assessing older adults in
the clinical context, and as recently stated by Pilotto et al. in an
extensive review of CGA it is the tool of choice to determine
the clinical profile, risks, and prognosis of older adults [9].
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Figure 1: Kernel density plot of the 30-item next-of-kin frailty index by age category: (a) women and (b) men.
The FI-CGA was aimed at generating an index that could be
easily drawn from clinical data [10].
In addition to currently used sources to integrate a FI,
relatives have been shown to provide reliable data in diverse
settings as proxies; this approach has been intended also to
integrate FI with accurate and reliable results, comparable
to a regular FI; nevertheless this index was constructed by
proxy of an alive older adult [11]. On the other hand, a frailty
index constructed from information provided by family or
related persons of a deceased older adult could give a clear
picture on how the last months of life of the older adult were.
Therefore the aim of this study is to construct a frailty index
with data provided by next-of-kin of the last year of life of
community-dwellingMexican older adults from theMexican
Health and Aging Study (MHAS) and test its association with
adverse health-related outcomes in order to assess its validity.
Our hypothesis is that a FI constructed from next-of-kin
information would be similar to those alive older adults with
poor health and will have an independent association with
the adverse outcomes.
2. Methods
We report data from the third wave of the MHAS (2012).
MHAS is a cohort study that currently has four rounds, the
last one in 2015, whose main objective is to analyze how
Mexican adults age. Complete aims and description of this
study are available elsewhere [12].This round included a set of
questionnaires that were answered by a member of the family
of the deceased (i.e., the last year of life of a community-
dwelling older adult).
Regarding FI, it was composed following the standardized
procedure by Searle et al., which includes transforming each
variable into a score of 0 (deficit absent) to 1 (deficit present)
with possible intermediate scores [13]. All deficit scores were
summed and then divided by 30 (total number of deficits in
the current list) for each participant, with total scores for the
FI ranging from0 (no deficit present) to 1 (all deficits present).
Deficits included in this index were from different domains:
self-rated health, comorbidities, mental health, and somatic
symptoms (see Table 1 for detail).
In order to test the hypothesis, adverse outcomes were
defined as higher use of health services. The first one was
the number of times the older adult visited a physician to his
office (as an outpatient) for any reason. The second one was
the number of times an older adult had overnight stays at a
hospital.
In order to adjust for the years from death, differences
between the years of death and the FI were tested. In
addition, models were also adjusted for this variable. The
proxy was always asked to remember the last year of life of
the deceased, both for the FI items and the adverse outcomes,
with questions beginning with “In the last year of life. . ..”
The Institutional Review Boards or Ethics Committees
of the University of Texas Medical Branch in the United
States, the Instituto Nacional de Estadistica y Geografia, and
the Instituto Nacional de Salud Pu´blica in Mexico approved
the study. The study adhered to the ethical guidelines of the
Declaration of Helsinki and all next-of-kin signed informed
consent, as well as all participants when study started.
3. Results
From a total of 2,743 40-year or older individuals (age at
time of death) the mean of age was 74.8 (±11.4) and 56.3%
(𝑛 = 1,183) were women. The mean of the 30-item frailty
index (30i-FI) was of 0.279 (±SD 0.131), with a minimum of
zero and a maximum of 0.738 (Table 1).
Distribution of the index was skewed to the right both for
men and women; however it was more skewed for women as
can be seen in Figure 1. In this same figure, the skewness is
lower as the age gets higher also for both men and women
(Figure 1).
There was a significant association (𝑝 < 0.001) between
the index and number of hospitalized days with a beta
coefficient of 46.04 (95% CI 36.5–55.5) and for the number of
visits to a physician of 26.36 (95%CI 19.7–32.96) bothmodels
adjusted for age and sex. This means 5.3 more nights staying
at the hospital for each standard deviation of FI or 7.75 more
number of visits to a physician or for each standard deviation
of FI (Table 2).
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Table 1: General description of the sample including the variables of the frailty index.
Variable Mean (SD) or 𝑛 (%)
Age, mean (SD) 75.7 (10.7)
Age categories, 𝑛 (%)
40–59 184 (6.7)
60–69 640 (23.3)
70–79 849 (30.1)
80–89 777 (28.3)
≥90 293 (10.6)
Sex, 𝑛 (%)
Women 1,334 (48.6)
Men 1,409 (51.3)
The deceased had more weight with important medical decisions, 𝑛 (%) 1,099 (40.1)
Years of death, median (IQR) 4 (0–11)
Number of hospitalized days in the last year of life, mean (SD) 12.6 (33.8)
Visited a physician in the last year of life, mean (SD) 11.6 (22.1)
Variables included in the index∗
Self-rated health, 𝑛 (%)
Excellent 72 (2.6)
Very good 93 (3.3)
Good 717 (26.1)
Fair 989 (36)
Poor 872 (31.8)
Diabetes mellitus, 𝑛 (%) 892 (33.6)
Cancer, 𝑛 (%) 437 (16.5)
Lung disease, 𝑛 (%) 405 (15.2)
Heart attack, 𝑛 (%) 447 (16.8)
Stroke, 𝑛 (%) 252 (9.5)
Hepatitis, 𝑛 (%) 245 (9.2)
Tuberculosis, 𝑛 (%) 21 (0.7)
Falls, 𝑛 (%) 1,079 (40.7)
Fractures, 𝑛 (%) 290 (10.9)
Pain, 𝑛 (%) 1,368 (51.6)
Pneumonia, 𝑛 (%) 245 (9.2)
Urosepsis, 𝑛 (%) 475 (17.9)
Herpes, 𝑛 (%) 67 (2.5)
Accident, 𝑛 (%) 186 (7)
Dementia, 𝑛 (%) 298 (11.2)
Memory complaint, 𝑛 (%) 354 (13.3)
Incoherent conversations, 𝑛 (%) 543 (20.5)
Frequently confused, 𝑛 (%) 461 (17.4)
Bad judgment, 𝑛 (%) 932 (35.1)
Depression, 𝑛 (%) 1,150 (43.4)
Anorexia, 𝑛 (%) 732 (27.6)
Urinary incontinence, 𝑛 (%) 640 (24.1)
Weight loss, 𝑛 (%) 1,314 (49.6)
Received help with certain activities, 𝑛 (%) 1,491 (56.2)
Swelling feet/ankles, 𝑛 (%) 1,140 (43)
Dyspnea, 𝑛 (%) 815 (30.7)
Severe fatigue, 𝑛 (%) 1,150 (43.4)
Coughing or wheezing, 𝑛 (%) 894 (33.7)
Abdominal pain, 𝑛 (%) 828 (31.2)
30i-FINoK, mean (SD) 0.279 (0.131)
30i-FINoK = 30-item frailty index from next-of-kin data.
∗Information is obtained from next-of-kin of the deceased regarding what happened in the last 12 months.
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4. Discussion
As shown by our data a frailty index is feasible to be con-
structed from data provided by next-of-kin. Characteristics
of the descriptive statistics and the distribution of the 30i-
FI are similar to those reported in indexes constructed from
other data sources, such as the higher burden of frailty in
women [10, 14]. As expected, the distribution of the 30i-FI
is biased to the right, which is characteristic of those older
adults in the lower spectrum of health [14].
One of the main flaws of this work is the lack of objective
measurements included in the index, which could lead to a
memory bias coming from the proxy. On the other hand,
frail older adults may have not visited as frequent as could
have done it because of their vulnerability status, somehow
underestimating the association with frailty. However, even
that there was an observed underestimation of the index in
those with more number of years deceased, when contrasting
to health care use, adjusted models for this variable did not
affect the estimates of the association. That is, a FI with data
provided by next-of-kin could be useful to test economic
analysis hypothesis such as cost analyses during the last
period of life. On the other hand, our findings are amenable to
be reproduced in other populations and having information
fromother sources, such asmedical files. Some concerns arise
when using parametric statistics with the frailty index, due
to its biased distribution; however in this work the shifting
towards the right allowed assuming a normal distribution and
performing a linear regression.
Previous research in this cohort showed that a cut-
off point of 0.21 in the frailty index was associated with
higher mortality [15]. When looking at our results, the mean
of the 30i-FI is above that cut-off point, which shows a
highly deteriorated population, and as actually happened,
with higher mortality. Also inMexican older adults the index
was found to be higher in women than in men and with
a trend to bias to the right as age increases [16]; however
these changes with sex and age categories were less evident
in this report, in part due to the more homogeneous group;
nevertheless still this phenomenon can be seen in the shown
data. Careful interpretation should be made specially with
those groups with a low number of subjects (i.e., ≥90 years
old for men and women); because goodness-of-fit was low
for these groups in the regression models (data not shown),
further research should corroborate our findings with higher
number of subjects in these groups. In addition, there is
also scarce information on how frailty could be interpreted
in younger adults, as shown in the first age category we
presented (40–59); however some data point to the fact that
frailty has a close relationship with age, even in younger
subjects, since it is thought to be an accurate marker of
biological age [17].
The appropriate stratification of older adults has been a
concern long ago in geriatric medicine. This is particularly
true when it comes to determine if an older adult is frail.
A considerable number of tools have been developed to
determine if an older adult is frail or not [18]. However, when
it comes to stratification of risk in these age groups other
tools have been also developed such as the multidimensional
prognostic index that incorporates a number of variables
of different domains and has shown accurate prediction
of adverse outcomes [19]. Along with frailty tools, other
stratification strategies should be tested in different contexts
such as next-of-kin in order to have a higher number of
options to assess older adults accurately.
5. Conclusion
The 30i-FI was gathered with information provided by a
proxy and was independently associated with an increased
use of health care in the last year of life of the elderly. This
methodology could be used in other contexts and it could aid
in the assessment of quality of care and health trajectories of
terminal older adults.
Conflicts of Interest
Authors have no conflicts of interest to declare.
References
[1] M. J. Prince, F. Wu, Y. Guo et al., “The burden of disease in
older people and implications for health policy and practice,”
The Lancet, vol. 385, no. 9967, pp. 549–562, 2015.
[2] J. E. Morley, M. T. Haren, Y. Rolland, and M. J. Kim, “Frailty,”
Medical Clinics of North America, vol. 90, no. 5, pp. 837–847,
2006.
[3] J. E. Morley, “Sarcopenia in the elderly,” Family Practice, vol. 29,
supplement 1, pp. i44–i48, 2012.
[4] J. E. Morley, B. Vellas, G. A. van Kan et al., “Frailty consensus:
a call to action,” Journal of the American Medical Directors
Association, vol. 14, no. 6, pp. 392–397, 2013.
[5] J. E. Morley, “Frailty screening comes of age,” Journal of
Nutrition, Health and Aging, vol. 18, no. 5, pp. 453–454, 2014.
[6] K. Rockwood, X. Song, C. MacKnight et al., “A global clinical
measure of fitness and frailty in elderly people,” CMAJ, vol. 173,
no. 5, pp. 489–495, 2005.
[7] D. M. Jones, X. Song, and K. Rockwood, “Operationalizing
a frailty index from a standardized comprehensive geriatric
assessment,” Journal of the American Geriatrics Society, vol. 52,
no. 11, pp. 1929–1933, 2004.
[8] M. Cesari, N. Costa, E. O. Hoogendijk, B. Vellas, M. Canevelli,
and M. U. Pe´rez-Zepeda, “How the frailty index may support
the allocation of health care resources: an example from the
INCUR study,” Journal of the American Medical Directors
Association, vol. 17, no. 5, pp. 448–450, 2016.
[9] A. Pilotto, A. Cella, A. Pilotto et al., “Three decades of compre-
hensive geriatric assessment: evidence coming from different
healthcare settings and specific clinical conditions,” Journal of
the American Medical Directors Association, vol. 18, no. 2, pp.
192.e1–192.e11, 2017.
[10] D. Jones, X. Song, A. Mitnitski, and K. Rockwood, “Evaluation
of a frailty index based on a comprehensive geriatric assessment
in a population based study of elderly Canadians,”AgingClinical
and Experimental Research, vol. 17, no. 6, pp. 465–471, 2005.
[11] J. Goldstein, R. E. Hubbard, P. Moorhouse, M. K. Andrew,
A. Mitnitski, and K. Rockwood, “The validation of a care
partner-derived frailty index based upon comprehensive geri-
atric assessment (CP-FI-CGA) in emergency medical services
6 BioMed Research International
and geriatric ambulatory care,” Age and Ageing, vol. 44, no. 2,
pp. 327–330, 2015.
[12] R.Wong, A.Michaels-Obregon, andA. Palloni, “Cohort profile:
The Mexican Health and Aging Study (MHAS),” International
Journal of Epidemiology, 2015.
[13] S. D. Searle, A. Mitnitski, E. A. Gahbauer, T. M. Gill, and K.
Rockwood, “A standard procedure for creating a frailty index,”
BMC Geriatrics, vol. 8, article 24, 2008.
[14] K. Rockwood, A.Mogilner, andA.Mitnitski, “Changes with age
in the distribution of a frailty index,”Mechanisms of Ageing and
Development, vol. 125, no. 7, pp. 517–519, 2004.
[15] J. J. Garc´ıa-Gonza´lez, C. Garc´ıa-Pen˜a, F. Franco-Marina, and L.
M. Gutie´rrez-Robledo, “A frailty index to predict the mortality
risk in a population of senior mexican adults,” BMC Geriatrics,
vol. 9, no. 1, article 47, 2009.
[16] M. U. Pe´rez-Zepeda, J. A. A´vila-Funes, L. M. Gutie´rrez-
Robledo, and C. Garc´ıa-Pen˜a, “Frailty across age groups,” The
Journal of Frailty & Aging, vol. 5, no. 1, pp. 15–19, 2016.
[17] A. Mitnitski, X. Song, and K. Rockwood, “Assessing biological
aging: the origin of deficit accumulation,” Biogerontology, vol.
14, no. 6, pp. 709–717, 2013.
[18] K. Rockwood, D. B. Hogan, and C. MacKnight, “Conceptuali-
sation and measurement of frailty in elderly people,” Drugs and
Aging, vol. 17, no. 4, pp. 295–302, 2000.
[19] A. Pilotto, D. Sancarlo, F. Panza et al., “The multidimensional
prognostic index (MPI), based on a comprehensive geriatric
assessment predicts short- and long-term mortality in hospi-
talized older patients with dementia,” Journal of Alzheimer’s
Disease, vol. 18, no. 1, pp. 191–199, 2009.
Submit your manuscripts at
https://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
